Rifaximin serves as a gut-selective rifamycin derivative for managing irritable bowel syndrome and hepatic encephalopathy. Its local action in the gastrointestinal tract minimizes systemic absorption while effectively modulating intestinal flora.
Rifaximin belongs to the rifamycin class of antibiotics and is not absorbed significantly into the bloodstream when taken orally. Its primary purpose is to act within the gastrointestinal tract, where it targets bacterial overgrowth. The compound is the active ingredient found in several Rifaximin-based products approved for use in Singapore.
In Singapore, the drug is supplied mainly as oral tablets, with strengths that vary between generic and brand versions. These tablets are marketed under the name Rifaximin and are also available in combination with other agents in certain multi-ingredient preparations. Both locally manufactured generics and internationally sourced brands meet the health authority’s standards for safety and quality.
Rifaximin is commonly employed to address the following conditions:
These uses rely on the drug’s ability to stay within the gut and limit bacterial proliferation without extensive systemic exposure.
When the tablet dissolves in the intestine, the medication binds to bacterial DNA-dependent RNA polymerase, interrupting the synthesis of essential proteins. This action halts bacterial growth and helps restore a more balanced microbial environment. Because very little drug reaches the bloodstream, the effect is largely confined to the digestive system.
The tablets should be stored in a cool, dry place away from direct sunlight, and kept out of reach of children. Treatment length differs: acute infections may require a short course of a few days, while chronic conditions like hepatic encephalopathy often involve longer-term administration. For detailed usage, dosing, and administration, refer to the specific medication’s clinical information.
This article provides an educational overview of Rifaximin as an active substance and does not constitute medical advice. Individual Rifaximin medicines may differ in formulation, strength, and directions for use. The information presented carries no liability for clinical application. Readers should consult the labeling of their specific medication and seek guidance from a healthcare professional.